← all works
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The EMBO Journal
- Topic
- Nanoplatforms for cancer theranostics
- Field
- Engineering
- Canadian institutions
- —
- Funders
- Fonds Wetenschappelijk OnderzoekFonds De La Recherche Scientifique - FNRSKU LeuvenVlaamse regeringServierUniversiteit GentFundacja na rzecz Nauki PolskiejEuropean Regional Development FundUniversity of Alberta
- Keywords
- BiologyCalreticulinImmunogenic cell deathSecretionProgrammed cell deathCancerCancer researchImmunologyCell biologyCancer cellEndoplasmic reticulumApoptosisBiochemistryGenetics
- Has abstract in OpenAlex
- no